Gestation trophoblastic diseases: Management of cases with persistent low human chorionic gonadotropin results

Obstetrics and Gynecology Clinics of North America

Volumn 32, Issue 4, 2005, Pages 615-626

  Cole, Laurence A ^a   Kohorn, Ernest ^b   Smith, Harriet O ^c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; ESTROGEN; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

CHORIOCARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DRUG RESPONSE; ECTOPIC PREGNANCY; FEMALE; FOOD AND DRUG ADMINISTRATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYDATIDIFORM MOLE; HYPOPHYSIS; PREGNANCY; PREGNANCY TEST; PRIORITY JOURNAL; REVIEW; TROPHOBLASTIC DISEASE; TROPHOBLASTIC TUMOR;

CHORIONIC GONADOTROPIN; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; MENOPAUSE; PITUITARY GLAND; PRECANCEROUS CONDITIONS; PREGNANCY; UNNECESSARY PROCEDURES;

EID: 28344444773     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2005.08.005     Document Type: Review

References (35)

1. L.A. Cole, and S.A. Khanlian Inappropriate management of women with persistent low hCG results J Reprod Med 49 2004 423 432
2. S.A. Khanlian, H.O. Smith, and L.A. Cole Persistent low levels of hCG: a pre-malignant gestational trophoblastic disease Am J Obstet Gynecol 188 2003 1254 1259
3. L.A. Cole, and J.M. Sutton hCG tests in the management of gestational trophoblastic diseases Clin Obstet Gynecol 46 2003 533 540
4. L.A. Cole Use of hCG tests for evaluating trophoblastic diseases: choosing an appropriate hCG assay, false detection of hCG, unexplained elevated hCG, and quiescent trophoblastic disease B.W. Hancock E.S. Newlands R.S. Berkowitz Gestational trophoblastic disease 2nd edition 2003 Sheffield University Press Sheffield 130 155 Available at: http://www.isstd.org/gtd/index. html
5. L.A. Cole, and J.M. Sutton Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases J Reprod Med 49 2004 545 553
6. B.W. Hancock, and J.A. Tidy Clinical management of persistent low level hCG elevation Trophobl Dis Upd 4 2004 5 6
7. E.I. Kohorn Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma Gynecol Oncol 85 2002 315 320
8. S. Rotmensch, and L.A. Cole False diagnosis and needles therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations Lancet 355 2000 712 715
9. L.A. Cole, and S.A. Butler False positive or phantom hCG result: a serious problem Clin Lab Intl 25 2001 9 14
10. L.A. Cole Phantom hCG and phantom choriocarcinoma Gynecol Oncol 71 1998 325 329
11. L.A. Cole, K.M. Rinne, and S. Shababi False positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma Clin Chem 45 1999 313 314
12. S.A. Butler, and L.A. Cole The use of heterophilic antibody blocking agent (HBT) in reducing false positive hCG results Clin Chem 47 2001 1332 1333
13. A.O. Vladutiu, J.M. Sulewski, and K.A. Pudlak Heterophilic antibodies interfering with radioimmunoassay: a false-positive pregnancy test JAMA 248 1982 2489 2490
14. T.G. Olsen, P.R. Hubert, and L.R. Nycum Falsely elevated human chorionic gonadotropin leading to unnecessary therapy Obstet Gynecol 98 2001 843 845
15. J.W. Chu, and J.O. Goldman False elevation of serum hCG: laboratory updates, Detroit Medical Center University Laboratories, 2003 Available at: http://www.dmc.org/univlab/jau_janice.htm
16. L. Rode, G. Daugaard, and M. Fenger Serum-hCG: still a problematic marker Acta Obstet Gynecol Scand 82 2003 199 200
17. N. Esfandiari, and J.M. Goldberg Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay Obstet Gynecol 101 2003 1144 1146
18. M.H. Billieux, P. Petignat, and J.L. Anguenot Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy Acta Obstet Gynecol Scand 82 2003 550 555
19. R. Hoermann, G. Spoettl, and R. Moncayo Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary J Clin Endocrinol Metab 71 1990 179 186
20. H. Suginami, and A. Kawaoi Immunohistochemical localization of a human chorionic gonadotropin-like substance in the human pituitary gland J Clin Endocrinol Metab 55 1982 1161 1166
21. R. Hoermann, G. Spoettl, and P. Berger Immunoreactive human chorionic gonadotropin beta core fragment in human pituitary Exp Clin Endocrinol Diabetes 103 1995 324 331
22. S. Birken, Y. Maydelman, and M.A. Gawinowicz Isolation and characterization of human pituitary chorionic gonadotropin Endocrinology 137 1996 1402 1411
23. G. Kovaleskaya, O. Genbacev, and S.J. Fisher Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source or choriocarcinoma-like hCG Mol Cell Endocrinol 194 2002 147 155
24. L.A. Cole, S. Shahabi, and U.A. Oz Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening Clin Chem 45 1999 2109 2119
25. M. Elliott, A. Kardana, and J.W. Lustbader Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma Endocrine 7 1997 15 32
26. L.A. Cole, S.A. Khanlian, and J.M. Sutton Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection Clin Biochem 36 2003 647 655
27. M. Ozturk, R. Berkowitz, and D. Goldstein Differential production of human chorionic gonadotropin and free beta subunits in gestational trophoblastic disease Am J Obstet Gynecol 158 1988 193 198
28. R.S. D'Agostino, L.A. Cole, and R.B. Ponn Urinary gonadotropin fragment in patients with lung and esophageal disease J Surg Oncol 49 1992 147 150
29. L.A. Cole, A. Tanaka, and G.S. Kim Beta core fragment (β-core / UGF / UGP), a tumor marker: seven year report Gynecol Oncol 60 1996 264 270
30. I. Marcillac, F. Toalen, and J.-M. Bidart Free human chorionic gonadotropin β-subunit in gonadal and nongonadal neoplasms Cancer Res 52 1992 3901 3907
31. H. Alfthan, C. Haglund, and P. Roberts Elevation of free β-subunit of human choriogonadotropin and core β fragment of choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease Cancer Res 52 1992 4628 4633
32. K. Rinne, S. Shahabi, and L.A. Cole Following metastatic placental site trophoblastic tumor with urine β-core fragment Gynecol Oncol 74 1999 302 303
33. R. Hoermann, G. Spoettl, and R. Moncayo Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary J Clin Endocrinol Metab 71 1990 179 186
34. B.W. Hancock E.S. Newlands R.S. Berkowitz Gestational trophoblastic disease 2003 Sheffield University Press Sheffield Available at: www.isstd.org
35. E.S. Newlands Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the UK B.W. Hancock E.S. Newland R.S. Berkowitz Gestational trophoblastic disease 1997 Chapman and Hall London 143 156